Literature DB >> 7526353

Fresh tissue harvest for research from prostatectomy specimens.

T M Wheeler1, R M Lebovitz.   

Abstract

As a consequence of molecular biological and genetic techniques, the demand for fresh tissue for basic research has increased dramatically at academic medical centers. Because of the extreme lability of many biological macromolecules, tissue must be harvested with the least possible delay from the time of removal. This necessity for quick action, frequently under less than optimal circumstances, along with the obvious loss of tissue available for diagnostic purposes, presents a daunting challenge to the pathologist responsible for accurate grading and staging of the cancer. A novel approach is described for the procurement of fresh and freshly frozen prostatic tissue with acceptable limitations on subsequent morphological analysis.

Entities:  

Mesh:

Year:  1994        PMID: 7526353     DOI: 10.1002/pros.2990250507

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

1.  Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.

Authors:  P Dehan; D Waltregny; A Beschin; A Noel; V Castronovo; K Tryggvason; J De Leval; J M Foidart
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 2.  Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.

Authors:  D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

3.  Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.

Authors:  Romain Mathieu; Shahrokh F Shariat; Christian Seitz; Pierre I Karakiewicz; Harun Fajkovic; Maxine Sun; Yair Lotan; Douglas S Scherr; Ashutosh Tewari; Francesco Montorsi; Alberto Briganti; Morgan Rouprêt; Ilaria Lucca; Vitaly Margulis; Michael Rink; Luis A Kluth; Malte Rieken; Alexander Bachman; Evanguelos Xylinas; Brian D Robinson; Karim Bensalah; Markus Margreiter
Journal:  World J Urol       Date:  2014-10-26       Impact factor: 4.226

4.  Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.

Authors:  S B Shappell; S Manning; W E Boeglin; Y F Guan; R L Roberts; L Davis; S J Olson; G S Jack; C S Coffey; T M Wheeler; M D Breyer; A R Brash
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

5.  The senescence-associated secretory phenotype promotes benign prostatic hyperplasia.

Authors:  Paz Vital; Patricia Castro; Susan Tsang; Michael Ittmann
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

6.  Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.

Authors:  Rile Li; Sibel Erdamar; Hong Dai; Thomas M Wheeler; Anna Frolov; Peter T Scardino; Timothy C Thompson; Gustavo E Ayala
Journal:  Hum Pathol       Date:  2007-06-26       Impact factor: 3.466

7.  Central quadrant procurement of radical prostatectomy specimens.

Authors:  Carl Morrison; Richard Cheney; Candace S Johnson; Gary Smith; James L Mohler
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

8.  Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.

Authors:  Malte Rieken; Luis A Kluth; Evanguelos Xylinas; Harun Fajkovic; Andreas Becker; Pierre I Karakiewicz; Michael Herman; Yair Lotan; Christian Seitz; Paul Schramek; Mesut Remzi; Wolfgang Loidl; Karl Pummer; Richard K Lee; Talia Faison; Douglas S Scherr; Alexandra Kautzky-Willer; Alexander Bachmann; Ashutosh Tewari; Shahrokh F Shariat
Journal:  World J Urol       Date:  2013-09-24       Impact factor: 4.226

9.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.

Authors:  Jeffrey C Weinreb; Jeffrey D Blume; Fergus V Coakley; Thomas M Wheeler; Jean B Cormack; Christopher K Sotto; Haesun Cho; Akira Kawashima; Clare M Tempany-Afdhal; Katarzyna J Macura; Mark Rosen; Scott R Gerst; John Kurhanewicz
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

10.  Frequent heterogeneous missense mutations of GGAP2 in prostate cancer: implications for tumor biology, clonality and mutation analysis.

Authors:  Yi Cai; Jianghua Wang; Chengxi Ren; Michael Ittmann
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.